Evidence map›Paper›PMID 24831650›Full record

ArticlePloS one2014

Population-based analysis of invasive nontypeable pneumococci reveals that most have defective capsule synthesis genes.

In Ho Park, K Aaron Geno, Logan K Sherwood, Moon H Nahm, Bernard Beall

Abstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed.

  1. Article
  2. Accurate serotype identification ofJournal of clinical microbiology · 2026
    Article
  3. Observational
  4. Article
  5. An abundance ofMicrobiology (Reading, England) · 2025
    Article
  6. Review
  7. AliC and AliD of nonencapsulatedFrontiers in cellular and infection microbiology · 2025
    Article
  8. Review
  9. Article
  10. Observational
  11. Endocarditis Caused by Nontypeable Streptococcus pneumoniae.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2022
    Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. The Best of All Worlds:Microorganisms · 2019
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

In Ho ParkDepartment of Pathology, University of Alabama at Birmingham, Birmingham, Alabama, United States of America.
K Aaron GenoDepartment of Pathology, University of Alabama at Birmingham, Birmingham, Alabama, United States of America.
Logan K SherwoodRespiratory Diseases Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
Moon H NahmDepartment of Pathology, University of Alabama at Birmingham, Birmingham, Alabama, United States of America; Department of Microbiology, University of Alabama at Birmingham, Birmingham, Alabama, United States of America.
Bernard BeallRespiratory Diseases Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.

Funding

Impact of a new group 6 serotype on pneumococcal vaccinesR01AI031473 · NIAID · WASHINGTON UNIVERSITY · PI NAHM, MOON H. · 1991 to 2011
$1.7M
Pneumococcal capsule and host innate immunityR56AI031473 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI NAHM, MOON H. · 2012 to 2012
$366k
NIAID NIH HHS AI-31473NIAID NIH HHS R01 AI031473NIAID NIH HHS R56 AI031473
6 · The paper itself

Abstract

Since nasopharyngeal carriage of pneumococcus precedes invasive pneumococcal disease, characteristics of carriage isolates could be incorrectly assumed to reflect those of invasive isolates. While most pneumococci express a capsular polysaccharide, nontypeable pneumococci are sometimes isolated. Carriage nontypeables tend to encode novel surface proteins in place of a capsular polysaccharide synthetic locus, the cps locus. In contrast, capsular polysaccharide is believed to be indispensable for invasive pneumococcal disease, and nontypeables from population-based invasive pneumococcal disease surveillance have not been extensively characterized. We received 14,328 invasive pneumococcal isolates through the Active Bacterial Core surveillance program during 2006-2009. Isolates that were nontypeable by Quellung serotyping were characterized by PCR serotyping, sequence analyses of the cps locus, and multilocus sequence typing. Eighty-eight isolates were Quellung-nontypeable (0.61%). Of these, 79 (89.8%) contained cps loci. Twenty-two nontypeables exhibited serotype 8 cps loci with defects, primarily within wchA. Six of the remaining nine isolates contained previously-described aliB homologs in place of cps loci. Multilocus sequence typing revealed that most nontypeables that lacked capsular biosynthetic genes were related to established non-encapsulated lineages. Thus, invasive pneumococcal disease caused by nontypeable pneumococcus remains rare in the United States, and while carriage nontypeables lacking cps loci are frequently isolated, such nontypeable are extremely rare in invasive pneumococcal disease. Most invasive nontypeable pneumococci possess defective cps locus genes, with an over-representation of defective serotype 8 cps variants.

Indexed as

Biosynthetic PathwaysCarrier StateGenes, BacterialHumansMultilocus Sequence TypingMutationNosePneumococcal InfectionsPolysaccharides, BacterialStreptococcus pneumoniaePolysaccharides, Bacterial

Identifiers

PMID24831650
PMCPMC4022640

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.